Literature DB >> 21576608

Determining the need for radical surgery in patients with T1 rectal cancer.

Harry M Salinas1, Abdulmetin Dursun, Coen L Klos, Paul Shellito, Patricia Sylla, David Berger, Liliana Bordeianou.   

Abstract

HYPOTHESIS: In the era of modern preoperative staging of patients with rectal cancer, lymph node metastases can be reliably predicted by the histological features of the tumor and preoperative imaging. Local resection can then be safely offered to the patients who are at low risk of having malignant lymph nodes.
DESIGN: We reviewed the records of 109 consecutive patients with preoperative imaging results suggestive of T1N0 or T2N0 disease who underwent total mesorectal excision. All patients underwent preoperative endorectal ultrasonography or magnetic resonance imaging and computed tomography, with or without positron emission tomography. Final pathologic investigation identified T3 disease in 27 patients. History, physical examination results, and radiologic and pathologic data were evaluated for predictors of positive nodes in the remaining 82 patients.
SETTING: Tertiary care referral center. PATIENTS: Patients with preoperative imaging suggestive of T1N0 or T2N0 rectal cancer. MAIN OUTCOME MEASURES: To evaluate different clinical and pathologic tumor features as predictors of positive lymph nodes in T1 and T2 rectal cancers with negative radiographic nodes.
BACKGROUND: Local resection of T1 and T2 rectal cancer results in lower morbidity compared with radical resection. However, recurrence rates after local resection are higher, likely owing to unresected nodal metastasis. Reports on predictors of lymph node metastasis remain inconsistent in the literature. Although local resection may be appropriate for some rectal cancers, selection criteria remain unclear.
RESULTS: Despite indications of negative nodes on radiographic examination, 4 of 35 patients with T1 disease (11%) and 13 of 47 with T2 disease (28%) had positive nodes. On univariate analysis, the only significant predictor was depth of invasion: 24 of 65 patients with negative nodes (37%) vs 13 of 17 patients with positive nodes (76%) had tumors invading the lower third of the submucosa and beyond (P = .02). On logistic regression analysis accounting for depth of invasion (lower third of the submucosa and beyond), size, distance from anal verge, differentiation, and lymphovascular and small-vessel invasion, only depth of invasion remained a significant predictor.
CONCLUSIONS: In all, 89% of patients with T1 disease (31 of 35) and 72% of those with T2 disease (34 of 47) underwent unnecessary radical resection. Endorectal ultrasonography or magnetic resonance imaging and computed tomography, with or without positron emission tomography, for preoperative staging could not identify these patients reliably. In addition, histologic markers of aggressive disease were not helpful. Thus, local resection for T2 rectal cancer is not justified. Local resection should be offered only to patients with superficial T1 tumors who will adhere to aggressive postoperative surveillance.

Entities:  

Mesh:

Year:  2011        PMID: 21576608     DOI: 10.1001/archsurg.2011.76

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

Review 1.  Advances in the management of colorectal cancer: from biology to treatment.

Authors:  Shahid Ahmed; Kate Johnson; Osama Ahmed; Nayyer Iqbal
Journal:  Int J Colorectal Dis       Date:  2014-06-24       Impact factor: 2.571

2.  Are we doing too much?: local excision before radical surgery in early rectal cancer.

Authors:  Sun Min Park; Bong-Hyeon Kye; Min Ki Kim; Heba E Jalloun; Hyeon-Min Cho; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2018-02-14       Impact factor: 2.571

Review 3.  The Role of Transanal Endoscopic Surgery for Early Rectal Cancer.

Authors:  Natalie F Berger; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

4.  A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.

Authors:  Tsuyoshi Ozawa; Raju Kandimalla; Feng Gao; Hiroaki Nozawa; Keisuke Hata; Hiroshi Nagata; Satoshi Okada; Daisuke Izumi; Hideo Baba; James Fleshman; Xin Wang; Toshiaki Watanabe; Ajay Goel
Journal:  Gastroenterology       Date:  2017-12-02       Impact factor: 22.682

5.  A simple scoring system for risk-stratifying rectal cancer patients prior to radical resection.

Authors:  P J Speicher; C Ligh; J E Scarborough; J K Thacker; C R Mantyh; R S Turley; J Migaly
Journal:  Tech Coloproctol       Date:  2013-10-02       Impact factor: 3.781

6.  Sentinel lymph node mapping procedure in T1 colorectal cancer: A systematic review of published studies.

Authors:  Stefano Di Berardino; Gabriella Teresa Capolupo; Chiara Caricato; Marco Caricato
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Oncologic outcomes and proper surveillance after local excision of rectal cancer.

Authors:  Yeong Cheol Im; Chan Wook Kim; Sunyoung Park; Jin Cheon Kim
Journal:  J Korean Surg Soc       Date:  2013-01-29

Review 8.  Lateral lymph node dissection for low rectal cancer: Is it necessary?

Authors:  Niki Christou; Jeremy Meyer; Christian Toso; Frédéric Ris; Nicolas Christian Buchs
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.